Study Identifies How Bacterial Sphingolipids Increase Membrane Stiffness
Researchers purified a novel anionic bacterial sphingolipid called ceramide phosphoglycerate (CPG) and found it increases membrane stiffness and zeta potential in bacterial cells. While bacteria were known to produce sphingolipids, the biophysical effects of these lipids on membrane properties had not been experimentally characterized. Understanding how these lipids affect membrane mechanics could inform research on bacterial physiology and potentially inform therapeutic approaches targeting bacterial membranes.
A new preprint study describes the isolation and characterization of ceramide phosphoglycerate (CPG), a novel anionic sphingolipid found in bacterial membranes. Using shotgun lipidomic analysis and experimental purification, researchers investigated how CPG and related sphingolipids affect membrane biophysical properties. The team found that both CPG and its precursor, ceramide 1-phosphate (C1P), increase the magnitude of membrane zeta potential—a measure of electrical charge at the membrane surface. More significantly, these sphingolipids increase membrane bending stiffness, with CPG producing greater rigidity than C1P or ceramide alone. The study also provides experimental and computational methods for isolating and characterizing bacterial sphingolipids, potentially enabling future research on other uncharacterized lipid species in bacterial membranes.
What's missing
The study does not discuss the biological function or evolutionary significance of these anionic sphingolipids in bacterial cells, nor does it address whether increased membrane stiffness confers selective advantages under specific environmental conditions. Additionally, the study's scope appears limited to in vitro characterization; the physiological relevance of these findings in living bacterial cells remains to be determined.
What different sources said
- bioRxivCenter
Anionic bacterial sphingolipids increase membrane stiffness
Related
Study Shows Statins Reduce Coenzyme Q in Brain Cells, Impairing Mitochondrial Function
A laboratory study found that statin drugs decrease coenzyme Q levels in astrocytes (brain support cells) by 30-40%, reducing their mitochondrial energy production and increasing oxidative stress. Astrocytes are critical for maintaining brain health and protecting neurons from damage. The findings suggest CoQ10 supplementation may help counteract these effects, though human clinical evidence remains limited.
Study reveals zebrafish larvae exhibit slowly fluctuating directional swim biases driven by internal dynamics
Researchers found that 5-day-old zebrafish larvae display changing directional swim preferences over many hours even in stable environments, contrary to classical models assuming constant individual biases. Computational analysis suggests these fluctuations arise from a non-stationary Markovian process with two independent internal input streams modulating swim direction repetition. The findings suggest animals possess intrinsic mechanisms for generating behavioral variability independent of external stimuli, with implications for understanding how internal states shape adaptive behavior.
Two Small Molecules Show Promise as Broad-Spectrum Coronavirus Inhibitors in Laboratory Study
Researchers found that sennoside A and ceftazidime, two small molecules, can inhibit RNA binding in the nucleocapsid proteins of SARS-CoV-2, SARS-CoV, and MERS-CoV in laboratory experiments. The nucleocapsid protein is highly conserved across coronaviruses and essential for viral replication, making it a potential drug target. The findings suggest these compounds could form the basis for pan-coronavirus antiviral therapies, though further development and clinical testing would be needed.